Search Results - "Ananicheva, N. A."

Hemodynamic Changes in Intrarenal Blood Flow are Associated With Poor Prognosis in Patients With Acute Decompensated Heart Failure by Sovetova, S A, Nikiforova, T A, Charaya, K V, Shchekochikhin, D Yu, Kulikov, V M, Dubovitsky, A M, Suchkova, S A, Bogdanova, A A, Ananicheva, N A, Andreev, D A

“…To evaluate a potential role of different patterns of intrarenal blood flow using Doppler ultrasound as a part of determining the severity of venous…”
Get more information

Development of a model for the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adult patients by Kupriushina, O. A., Strelkova, D. A., Yasneva, A. S., Rachina, S. A., Avdeev, S. N., Vlasenko, A. E., Fedina, L. V., Ivanova, O. V., Kaledina, I. V., Ananicheva, N. A.

“…Relevance. During and after the COVID-19 pandemic, viruses have become a more common cause of pulmonary infections in adults; therefore, the distinction…”
Get full text

Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study by Charaya, K. V., Shchekochikhin, D. Yu, Tarasenko, S. N., Ananicheva, N. A., Sovetova, S. A., Soboleva, T. V., Dikur, O. N., Borenstein, A. I., Andreev, D. A.

“…Aim . To analyze the clinical significance of the sodium level in a single urine test obtained 2 hours after the first dose of a loop diuretic was administered…”
Get full text

Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts by Lebedeva, A. Yu, Koteshkova, O. M., Dzhioeva, O. N., Gilyarevsky, S. R., Uskach, T. M., Novikova, M. S., Orlova, Ya. A., Kalashnikov, V. Yu, Privalov, D. V., Ananicheva, N. A., Gilyarov, M. Yu, Erlikh, A. D.

“…The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some…”
Get full text

CASE REPORT: THE POSSIBILITY OF SPECIFIC THERAPY OPTIMIZATION BY SWITCHING FROM BOSENTAN TO MACITENTAN IN A PATIENT WITH CONGENITAL HEART DISEASE AND EISENMENGER SYNDROME by Gratsianakaya, S. Ye, Arkhipova, O. A., Davydov, A. I., Martynyuk, T. V., Ananicheva, N. A., Belkorey, O. S., Chazova, I. Ye

“…A patient with pulmonary arterial hypertension (PAH) associated with congenital heart disease (ventricular septal defect) and Eisenmenger syndrome was started…”
Get full text